Vemurafenib: an unusual UVA-induced photosensitivity

BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAFV600Emutation

(2012) Kate Young et al.   Future Oncology

Ultraviolet A and Photosensitivity during Vemurafenib Therapy

(2012) Reinhard Dummer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interest of external photoprotection by means of clothing and sunscreen products in young children

(2011) S. Ghazi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

UVA filters in sun-protection products: regulatory and biological aspects

(2011) A. Fourtanier et al.   PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES

Pellagra: a review with emphasis on photosensitivity

(2010) P. Wan et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

(2010) Gideon Bollag et al.   NATURE

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population reference intervals for minimal erythemal doses in monochromator phototesting

(2009) Harry Moseley et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

C-Terminal Deletions in the ALAS2 Gene Lead to Gain of Function and Cause X-linked Dominant Protoporphyria without Anemia or Iron Overload

(2008) Sharon D. Whatley et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Solar urticaria

(2008) Nina C. Botto et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY